FDA Inspection
Hisamitsu Pharmaceutical Co., Inc.Hisamitsu Pharmaceutical Co., Inc. – FDA Inspection, Jul 11, 2025
Record Details
This FDA Inspection record concerns Hisamitsu Pharmaceutical Co., Inc., with an inspection on July 11, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · c6d60d6e-c743-4379-a81f-fb304ce7d4b2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1272611
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(c)Testing and standardization of standards et. al.
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.166(a)(3)Valid stability test methods
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hisamitsu Pharmaceutical Co., Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hisamitsu Pharmaceutical Co., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.